OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $2,300,000 Invested

2022

Quanterix Corporation

David Wilson, Ph.D.

Clinical Implementation of Blood-Based Biomarkers for Alzheimer’s Disease: Clinical Validation, IVD Product Development, and Market Development

  • Funding Amount: $2,300,000
  • Organization Type: Biotechnology/For Profit
  • Program: Diagnostics Accelerator
  • Target: Other
  • Status: Active